Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders.

dyslipidemia lipid metabolic disorder mesoporous silica nanoparticles miR-33 non-alcoholic fatty liver disease

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 11 12 2019
accepted: 05 06 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 28 8 2020
Statut: epublish

Résumé

Lipid metabolic disorders have become a major global public health concern. Fatty liver and dyslipidemia are major manifestations of these disorders. Recently, MicroRNA-33 (miR-33), a post-transcriptional regulator of genes involved in cholesterol efflux and fatty acid oxidation, has been considered as a good therapeutic target for these disorders. However, the traditional methods of gene therapy impede their further clinical transformation into a mature treatment system. To counter this problem, in this study we used mesoporous silica nanoparticles (MSNs) as nanocarriers to deliver miR-33 antagomirs developing nanocomposites miR-MSNs. We observed that the hepatocellular uptake of miR-33 antagomirs increased by ∼5 times when they were delivered using miR-MSNs. The regulation effects of miR-MSNs on miR-33 and several genes involved in lipid metabolism were confirmed in L02 cells. In a high-fat diet fed mice, miR-33 intervention

Identifiants

pubmed: 32848718
doi: 10.3389/fphar.2020.00921
pmc: PMC7419650
doi:

Types de publication

Journal Article

Langues

eng

Pagination

921

Informations de copyright

Copyright © 2020 Tao, Xu, Wang, Xu, Zhang, Chen, Lian, Zhou, Xie, Zheng and Xu.

Références

Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):582-7
pubmed: 26663005
Clin Med Insights Gastroenterol. 2018 Jul 10;11:1179552218787502
pubmed: 30013416
ACS Appl Mater Interfaces. 2016 Aug 3;8(30):19228-37
pubmed: 27381493
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Lancet Gastroenterol Hepatol. 2019 Sep;4(9):731-741
pubmed: 31387736
Biochemistry (Mosc). 2017 Jun;82(6):655-662
pubmed: 28601075
Science. 2010 Jun 18;328(5985):1570-3
pubmed: 20466885
Science. 2004 Aug 6;305(5685):869-72
pubmed: 15297675
Mol Pharm. 2018 Oct 1;15(10):4550-4557
pubmed: 30188729
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9774-9
pubmed: 15210959
Acta Biomater. 2018 Aug;76:178-192
pubmed: 30078423
Dig Liver Dis. 2017 Feb;49(2):188-196
pubmed: 27939923
JAMA. 1998 May 27;279(20):1615-22
pubmed: 9613910
Ecotoxicol Environ Saf. 2019 Apr 15;170:391-398
pubmed: 30550969
Artif Cells Nanomed Biotechnol. 2018;46(sup2):217-228
pubmed: 29560749
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
R Soc Open Sci. 2018 Nov 14;5(11):181457
pubmed: 30564426
Nature. 2011 Oct 19;478(7369):404-7
pubmed: 22012398
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9232-7
pubmed: 21576456
ACS Appl Mater Interfaces. 2019 Feb 6;11(5):4842-4857
pubmed: 30628769
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Gut. 2017 Jan;66(1):180-190
pubmed: 27646933
Int J Nanomedicine. 2017 Jul 24;12:5271-5287
pubmed: 28769563
J Steroid Biochem Mol Biol. 2015 Nov;154:94-103
pubmed: 26241028
Acta Pharm Sin B. 2018 Mar;8(2):165-177
pubmed: 29719777
Biomaterials. 2011 Feb;32(6):1657-68
pubmed: 21093905
J Hepatol. 2016 Dec;65(6):1245-1257
pubmed: 27486010
Biomaterials. 2018 Feb;154:147-157
pubmed: 29128843
Metabolism. 2016 Aug;65(8):1038-48
pubmed: 26823198
Biomaterials. 2019 Mar;197:1-11
pubmed: 30623792
J Med Assoc Thai. 1979 Jul;62(7):354-9
pubmed: 225401
Gastroenterology. 2015 Mar;148(3):547-55
pubmed: 25461851
Mol Cell Biol. 2013 Jun;33(11):2339-52
pubmed: 23547260
Nat Commun. 2019 Apr 30;10(1):1981
pubmed: 31040273
Small. 2011 Jan 17;7(2):271-80
pubmed: 21213393
Adv Mater. 2012 Mar 22;24(12):1504-34
pubmed: 22378538
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12228-32
pubmed: 20566875
Front Bioeng Biotechnol. 2020 Mar 10;8:184
pubmed: 32211399
Science. 2010 Jun 18;328(5985):1566-9
pubmed: 20466882
Hepatobiliary Pancreat Dis Int. 2017 Apr;16(2):176-180
pubmed: 28381382
J Biol Chem. 2010 Oct 29;285(44):33652-61
pubmed: 20732877
J Am Chem Soc. 2010 Apr 7;132(13):4834-42
pubmed: 20230032

Auteurs

Yaoye Tao (Y)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Shengjun Xu (S)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Jianguo Wang (J)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Li Xu (L)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Chenzhi Zhang (C)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Kangchen Chen (K)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Zhengxing Lian (Z)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Junbin Zhou (J)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Haiyang Xie (H)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Shusen Zheng (S)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Xiao Xu (X)

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
NHC Key Lab of Combined Multi-Organ Transplantation, Hangzhou, China.

Classifications MeSH